Author: Joe Paul Koola
-
Why the Biologics Patent Cliff Is Failing to Cut Drug Costs?
Between 2025 and 2029, there is going to be a profound impact on the Pharmaceutical industry, catalysed by the Loss of Exclusivity. The loss of exclusivity signifies the expiration of the patents of biologics, causing a systemwide erosion of the market exclusivity held by several major pharmaceutical companies, resulting in a revenue contraction for these…
-
Hidden Costs of AI-Assisted Coding & Global Best Practices Response
Artificial intelligence has fundamentally altered the economics of software development. Large Language Models embedded into coding environments now generate working code at a pace that would have been inconceivable just a few years ago. For firms facing competitive pressure, talent shortages, and compressed delivery timelines, AI-assisted coding appears to offer an almost frictionless productivity upgrade.…
-
Volatile Beauty: Riding the Highs and Lows of the Silver
A metal that is now present everywhere, from solar panels to circuits, from water purifiers to medical devices, from investments to jewellery. An element of elegance is oftentimes outshone by its sibling, the element of luxury. The lunar caustic, whose value was stripped down after its demonetization in 1873, is making a comeback, and it…